US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist

11.1500
+0.3600+3.34%

Close May 23 16:00 ET

10.7500
-0.4000-3.59%

Post 16:24 ET

11.53MMarket Cap-218P/E (TTM)

Avalo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

38.30%-6.2M

-14.69%-30.68M

29.80%-2.77M

-219.39%-6.84M

11.58%-11.03M

37.44%-10.05M

62.27%-26.75M

76.96%-3.94M

135.15%5.73M

35.01%-12.47M

Net income from continuing operations

-1,118.38%-121.29M

24.28%-31.54M

16.75%-8.17M

-263.78%-5.23M

36.91%-8.19M

54.85%-9.96M

50.63%-41.66M

48.89%-9.81M

118.35%3.19M

24.07%-12.99M

Operating gains losses

-33.33%120K

-87.65%720K

--600K

---100K

--40K

--180K

--5.83M

----

Depreciation and amortization

3.03%34K

-4.82%158K

22.86%43K

20.59%41K

36.67%41K

-50.75%33K

-89.98%166K

-88.14%35K

-92.53%34K

-93.42%30K

Deferred tax

-12.50%7K

-50.00%14K

-212.50%-9K

60.00%8K

16.67%7K

-11.11%8K

27.27%28K

144.44%8K

-44.44%5K

-40.00%6K

Other non cash items

32,917.43%115.56M

31.61%1.83M

--0

218.93%1.13M

3.87%349K

0.00%350K

74.94%1.39M

0.00%349K

3.81%354K

--336K

Change In working capital

17.07%-1.26M

-15,300.00%-9.24M

144.04%85K

-358.09%-3.64M

-173.34%-4.16M

-719.11%-1.52M

-102.11%-60K

54.16%-193K

196.71%1.41M

73.40%-1.52M

-Change in receivables

-90.49%101K

-38.09%1.78M

331.74%1.4M

-378.73%-1.49M

52.82%813K

-56.06%1.06M

795.65%2.88M

31.79%-605K

-55.56%536K

682.35%532K

-Change in inventory

--0

11.11%20K

--0

1,700.00%18K

-50.00%1K

-92.31%1K

151.43%18K

109.09%2K

-75.00%1K

110.00%2K

-Change in prepaid assets

54.30%-154K

-58.69%447K

156.40%97K

-74.58%195K

-38.27%492K

-8.71%-337K

277.00%1.08M

82.18%-172K

124.27%767K

11.47%797K

-Change in payables and accrued expense

47.65%-1.18M

-178.81%-11.48M

-237.49%-1.3M

-648.15%-2.42M

-93.46%-5.5M

-18.90%-2.26M

-201.80%-4.12M

111.38%947K

67.40%-324K

56.07%-2.84M

-Change in other current liabilities

-1,330.77%-186K

-744.44%-76K

-118.18%-24K

-83.33%-22K

-54.55%-17K

-152.00%-13K

80.00%-9K

-320.00%-11K

25.00%-12K

38.89%-11K

-Change in other working capital

618.18%158K

-20.45%70K

75.14%-88K

--88K

--48K

--22K

--88K

---354K

----

Cash from discontinued investing activities

Operating cash flow

38.30%-6.2M

-14.69%-30.68M

29.80%-2.77M

-219.39%-6.84M

11.58%-11.03M

37.44%-10.05M

62.27%-26.75M

76.96%-3.94M

135.15%5.73M

35.01%-12.47M

Investing cash flow

Cash flow from continuing investing activities

367.67%356K

-40.00%-133K

-133K

15.93%-95K

51.85%-39K

-56K

Net PPE purchase and sale

--0

126.32%25K

--0

--25K

15.93%-95K

--0

51.85%-39K

---56K

Net business purchase and sale

--356K

----

--0

----

Net other investing changes

----

---158K

--0

---158K

----

Cash from discontinued investing activities

Investing cash flow

367.67%356K

-40.00%-133K

--0

---133K

15.93%-95K

--0

51.85%-39K

---56K

Financing cash flow

Cash flow from continuing financing activities

690.02%108.61M

270.37%25.04M

-98.78%1K

10.7M

104.05%598K

13.75M

-113.77%-14.7M

7.89%82K

-169.66%-14.78M

Net issuance payments of debt

----

---21.24M

--0

---15.24M

----

--0

--14.81M

--0

----

Net common stock issuance

741.03%115.63M

412.88%46.22M

100.01%1K

--25.94M

--6.53M

--13.75M

-120.54%-14.77M

-17,914.63%-14.77M

--0

Proceeds from stock option exercised by employees

----

-8.22%67K

--0

----

-96.22%73K

-69.62%48K

--0

----

Net other financing activities

---7.01M

----

Cash from discontinued financing activities

Financing cash flow

690.02%108.61M

270.37%25.04M

-98.78%1K

--10.7M

104.05%598K

--13.75M

-113.77%-14.7M

7.89%82K

--0

-169.66%-14.78M

Net cash flow

Beginning cash position

-43.34%7.55M

-75.72%13.32M

-39.97%10.31M

-43.84%6.45M

-56.49%16.88M

-75.72%13.32M

187.15%54.86M

-76.11%17.18M

-71.72%11.49M

0.52%38.8M

Current changes in cash

2,784.25%102.77M

86.11%-5.77M

28.33%-2.77M

-32.14%3.86M

61.81%-10.43M

122.18%3.56M

-216.19%-41.55M

77.35%-3.86M

-81.81%5.69M

-1,444.51%-27.31M

End cash Position

553.47%110.31M

-43.33%7.55M

-39.97%10.31M

-43.84%6.45M

-56.49%16.88M

-75.72%13.32M

-76.11%17.18M

-71.72%11.49M

Free cash flow

38.30%-6.2M

-14.28%-30.68M

29.80%-2.77M

-220.20%-6.84M

11.98%-11.03M

37.44%-10.05M

62.19%-26.85M

76.97%-3.94M

134.74%5.69M

34.72%-12.53M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	38.30%-6.2M	-14.69%-30.68M	29.80%-2.77M	-219.39%-6.84M	11.58%-11.03M	37.44%-10.05M	62.27%-26.75M	76.96%-3.94M	135.15%5.73M	35.01%-12.47M
Net income from continuing operations	-1,118.38%-121.29M	24.28%-31.54M	16.75%-8.17M	-263.78%-5.23M	36.91%-8.19M	54.85%-9.96M	50.63%-41.66M	48.89%-9.81M	118.35%3.19M	24.07%-12.99M
Operating gains losses	-33.33%120K	-87.65%720K	--600K	---100K	--40K	--180K	--5.83M	----	----	----
Depreciation and amortization	3.03%34K	-4.82%158K	22.86%43K	20.59%41K	36.67%41K	-50.75%33K	-89.98%166K	-88.14%35K	-92.53%34K	-93.42%30K
Deferred tax	-12.50%7K	-50.00%14K	-212.50%-9K	60.00%8K	16.67%7K	-11.11%8K	27.27%28K	144.44%8K	-44.44%5K	-40.00%6K
Other non cash items	32,917.43%115.56M	31.61%1.83M	--0	218.93%1.13M	3.87%349K	0.00%350K	74.94%1.39M	0.00%349K	3.81%354K	--336K
Change In working capital	17.07%-1.26M	-15,300.00%-9.24M	144.04%85K	-358.09%-3.64M	-173.34%-4.16M	-719.11%-1.52M	-102.11%-60K	54.16%-193K	196.71%1.41M	73.40%-1.52M
-Change in receivables	-90.49%101K	-38.09%1.78M	331.74%1.4M	-378.73%-1.49M	52.82%813K	-56.06%1.06M	795.65%2.88M	31.79%-605K	-55.56%536K	682.35%532K
-Change in inventory	--0	11.11%20K	--0	1,700.00%18K	-50.00%1K	-92.31%1K	151.43%18K	109.09%2K	-75.00%1K	110.00%2K
-Change in prepaid assets	54.30%-154K	-58.69%447K	156.40%97K	-74.58%195K	-38.27%492K	-8.71%-337K	277.00%1.08M	82.18%-172K	124.27%767K	11.47%797K
-Change in payables and accrued expense	47.65%-1.18M	-178.81%-11.48M	-237.49%-1.3M	-648.15%-2.42M	-93.46%-5.5M	-18.90%-2.26M	-201.80%-4.12M	111.38%947K	67.40%-324K	56.07%-2.84M
-Change in other current liabilities	-1,330.77%-186K	-744.44%-76K	-118.18%-24K	-83.33%-22K	-54.55%-17K	-152.00%-13K	80.00%-9K	-320.00%-11K	25.00%-12K	38.89%-11K
-Change in other working capital	618.18%158K	-20.45%70K	75.14%-88K	--88K	--48K	--22K	--88K	---354K	----	----
Cash from discontinued investing activities
Operating cash flow	38.30%-6.2M	-14.69%-30.68M	29.80%-2.77M	-219.39%-6.84M	11.58%-11.03M	37.44%-10.05M	62.27%-26.75M	76.96%-3.94M	135.15%5.73M	35.01%-12.47M
Investing cash flow
Cash flow from continuing investing activities	367.67%356K	-40.00%-133K	0	0	0	-133K	15.93%-95K	0	51.85%-39K	-56K
Net PPE purchase and sale	--0	126.32%25K	--0	--0	--0	--25K	15.93%-95K	--0	51.85%-39K	---56K
Net business purchase and sale	--356K	----	----	----	----	--0	----	----	----	----
Net other investing changes	----	---158K	--0	--0	--0	---158K	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	367.67%356K	-40.00%-133K	--0	--0	--0	---133K	15.93%-95K	--0	51.85%-39K	---56K
Financing cash flow
Cash flow from continuing financing activities	690.02%108.61M	270.37%25.04M	-98.78%1K	10.7M	104.05%598K	13.75M	-113.77%-14.7M	7.89%82K	0	-169.66%-14.78M
Net issuance payments of debt	----	---21.24M	--0	---15.24M	----	----	--0	--14.81M	--0	----
Net common stock issuance	741.03%115.63M	412.88%46.22M	100.01%1K	--25.94M	--6.53M	--13.75M	-120.54%-14.77M	-17,914.63%-14.77M	--0	--0
Proceeds from stock option exercised by employees	----	-8.22%67K	--0	--0	----	----	-96.22%73K	-69.62%48K	--0	----
Net other financing activities	---7.01M	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	690.02%108.61M	270.37%25.04M	-98.78%1K	--10.7M	104.05%598K	--13.75M	-113.77%-14.7M	7.89%82K	--0	-169.66%-14.78M
Net cash flow
Beginning cash position	-43.34%7.55M	-75.72%13.32M	-39.97%10.31M	-43.84%6.45M	-56.49%16.88M	-75.72%13.32M	187.15%54.86M	-76.11%17.18M	-71.72%11.49M	0.52%38.8M
Current changes in cash	2,784.25%102.77M	86.11%-5.77M	28.33%-2.77M	-32.14%3.86M	61.81%-10.43M	122.18%3.56M	-216.19%-41.55M	77.35%-3.86M	-81.81%5.69M	-1,444.51%-27.31M
End cash Position	553.47%110.31M	-43.33%7.55M	-43.33%7.55M	-39.97%10.31M	-43.84%6.45M	-56.49%16.88M	-75.72%13.32M	-75.72%13.32M	-76.11%17.18M	-71.72%11.49M
Free cash flow	38.30%-6.2M	-14.28%-30.68M	29.80%-2.77M	-220.20%-6.84M	11.98%-11.03M	37.44%-10.05M	62.19%-26.85M	76.97%-3.94M	134.74%5.69M	34.72%-12.53M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall